From RT.com…
The drug, called Leitragin, was developed by the Biomedical Technology Research Center of the Russian Federal Medical and Biology Agency (FMBA), and is currently undergoing clinical trials in Russia. Although its base substance was previously known and used in ulcer treatment medicine by Soviet and Russian doctors, it was the FMBA team that discovered how to apply it for the treatment of severe cases of Covid-19 and, potentially, other deadly diseases that cause life-threatening lung inflammation.
The Russian scientists had tasked themselves with finding a substance that would act as an ‘off switch’ for the chain reaction that, after being triggered by the invading SARS-CoV-2 virus, actually causes potential organ failure and death. This reaction of the immune system, dubbed the “cytokine storm,” has been variously described as our body’s overreaction to the virus or a “suicide attack” against the invading pathogen, and even as an evolutionary mechanism to stop the spread of deadly infections with the death of the host.
